Shares of IceCure Medical Ltd (NASDAQ:ICCM – Get Free Report) were down 3.3% during trading on Wednesday . The company traded as low as $1.17 and last traded at $1.17. Approximately 287,875 shares were traded during trading, a decline of 52% from the average daily volume of 601,639 shares. The stock had previously closed at $1.21.
Wall Street Analyst Weigh In
ICCM has been the subject of a number of analyst reports. HC Wainwright reiterated a “buy” rating and set a $3.00 price objective on shares of IceCure Medical in a report on Tuesday, April 16th. Alliance Global Partners boosted their price objective on IceCure Medical from $1.90 to $2.90 and gave the stock a “buy” rating in a report on Wednesday, March 20th.
Check Out Our Latest Stock Analysis on IceCure Medical
IceCure Medical Stock Down 3.3 %
IceCure Medical (NASDAQ:ICCM – Get Free Report) last released its quarterly earnings results on Wednesday, April 3rd. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.01. The business had revenue of $1.26 million for the quarter. IceCure Medical had a negative net margin of 453.76% and a negative return on equity of 86.96%. During the same quarter last year, the firm posted ($0.11) earnings per share. As a group, sell-side analysts forecast that IceCure Medical Ltd will post -0.28 EPS for the current fiscal year.
IceCure Medical Company Profile
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Featured Stories
- Five stocks we like better than IceCure Medical
- Why Invest in 5G Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Invest in Blue Chip Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Investing in large cap stocks: Diving into big caps
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.